D

Dynavax Technologies

319 employees

Dynavax Technologies is a biopharmaceutical company discovering and developing novel products to prevent and treat infectious diseases.

Basic info

Industry

biotechnology research

Sectors

Biodefense
Vaccine Manufacturing and Vaccines
Biotechnology
Medical Device
Health Care
Infectious Diseases
Biopharma
Clinical Trials

Date founded

1996

Funding rounds raised

Total raised

$175M

from 5 investors over 5 rounds

D

Dynavax Technologies raised $99M on February 1, 2021

Investors: CEPI (Coalition for Epidemic Preparedness Innovations)

D

Dynavax Technologies raised $3.4M on August 13, 2020

Investors: Bill & Melinda Gates Foundation

D

Dynavax Technologies raised $175M on February 20, 2018

Investors: CRG LP

D

Dynavax Technologies raised $40M on December 29, 2014

Investors: Hercules Capital, Inc.

D

Dynavax Technologies raised $600K on September 7, 2011

Investors: National Institute of Allergy and Infectious Diseases (NIAID)

FAQ